Home/Filings/4/0000950170-25-104399
4//SEC Filing

Arif Bilal 4

Accession 0000950170-25-104399

CIK 0000873303other

Filed

Aug 5, 8:00 PM ET

Accepted

Aug 6, 8:03 PM ET

Size

5.8 KB

Accession

0000950170-25-104399

Insider Transaction Report

Form 4
Period: 2025-08-05
Arif Bilal
Chief Tech Ops Officer
Transactions
  • Award

    Performance Stock Units

    2025-08-05+6,2506,250 total
    Common Stock (6,250 underlying)
Footnotes (1)
  • [F1]Represents the number of shares earned under a PSU award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the prescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 1, 2026, subject to the Reporting Person continuing to provide service to the Company through such vesting date.

Documents

1 file

Issuer

Sarepta Therapeutics, Inc.

CIK 0000873303

Entity typeother

Related Parties

1
  • filerCIK 0001959750

Filing Metadata

Form type
4
Filed
Aug 5, 8:00 PM ET
Accepted
Aug 6, 8:03 PM ET
Size
5.8 KB